AQR Capital Management

AQR Capital Management Portfolio holdings

AUM $191B
1-Year Est. Return 25.77%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+25.77%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$156B
AUM Growth
+$35.1B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
3,631
New
Increased
Reduced
Closed

Top Buys

1
+$854M
2
+$758M
3
+$464M
4
PEP icon
PepsiCo
PEP
+$462M
5
FDX icon
FedEx
FDX
+$396M

Top Sells

1
+$332M
2
+$319M
3
+$252M
4
MNST icon
Monster Beverage
MNST
+$227M
5
COST icon
Costco
COST
+$216M

Sector Composition

1 Technology 24.74%
2 Financials 14.8%
3 Industrials 12.02%
4 Healthcare 11.96%
5 Consumer Discretionary 11.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCHB
3501
Mechanics Bancorp
MCHB
$3.38B
– –
-13,190
BWIN
3502
Baldwin Insurance Group
BWIN
$2.62B
– –
-9,263
CCCC icon
3503
C4 Therapeutics
CCCC
$299M
– –
-383,789
LQD icon
3504
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$31.1B
– –
-2,108
QIPT
3505
Quipt Home Medical
QIPT
$162M
– –
-13,418
QQEW icon
3506
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
$1.73B
– –
-1,787
RDFN
3507
DELISTED
Redfin
RDFN
– –
-60,631
RDUS
3508
DELISTED
Radius Recycling
RDUS
– –
-58,795
RDZN icon
3509
Roadzen
RDZN
$104M
– –
-22,156
LNAI
3510
Lunai Bioworks
LNAI
$9.22M
– –
-1,041
REPL icon
3511
Replimune Group
REPL
$599M
– –
-12,212
SAGE
3512
DELISTED
Sage Therapeutics
SAGE
– –
-861,366
SAVA icon
3513
Cassava Sciences
SAVA
$107M
– –
-29,782
XOP icon
3514
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$2.64B
– –
-3,292
YMAB
3515
DELISTED
Y-mAbs Therapeutics
YMAB
– –
-252,142
ZYXI
3516
DELISTED
Zynex
ZYXI
– –
-35,584
FBLG icon
3517
FibroBiologics
FBLG
$25M
– –
-52,217
GUTS icon
3518
Fractyl Health
GUTS
$76.5M
– –
-64,700
MGX icon
3519
Metagenomi Therapeutics
MGX
$60.1M
– –
-129,055
NNOX icon
3520
Nano X Imaging
NNOX
$173M
– –
-13,482
CBUS icon
3521
Cibus
CBUS
$220M
– –
-12,636
ABOS icon
3522
Acumen Pharmaceuticals
ABOS
$200M
– –
-46,292
ACHV icon
3523
Achieve Life Sciences
ACHV
$244M
– –
-25,300
ACRV icon
3524
Acrivon Therapeutics
ACRV
$53.3M
– –
-22,252
ADX icon
3525
Adams Diversified Equity Fund
ADX
$2.84B
– –
-12,151
139 140
141
142 143